Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III
Publication
, Journal Article
Becker, RC
Published in: Journal of Thrombosis and Thrombolysis
1995
Duke Scholars
Published In
Journal of Thrombosis and Thrombolysis
DOI
ISSN
0929-5305
Publication Date
1995
Volume
2
Issue
1
Start / End Page
29 / 35
Related Subject Headings
- Cardiovascular System & Hematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (1995). Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III. Journal of Thrombosis and Thrombolysis, 2(1), 29–35. https://doi.org/10.1007/BF01063158
Becker, R. C. “Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III.” Journal of Thrombosis and Thrombolysis 2, no. 1 (1995): 29–35. https://doi.org/10.1007/BF01063158.
Becker RC. Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III. Journal of Thrombosis and Thrombolysis. 1995;2(1):29–35.
Becker, R. C. “Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III.” Journal of Thrombosis and Thrombolysis, vol. 2, no. 1, 1995, pp. 29–35. Scival, doi:10.1007/BF01063158.
Becker RC. Importance of clinical trials in developing safe and effective treatments for acute myocardial infarction: From TIMI II to TIMI 9, GUSTO II, and HIT III. Journal of Thrombosis and Thrombolysis. 1995;2(1):29–35.
Published In
Journal of Thrombosis and Thrombolysis
DOI
ISSN
0929-5305
Publication Date
1995
Volume
2
Issue
1
Start / End Page
29 / 35
Related Subject Headings
- Cardiovascular System & Hematology
- 1103 Clinical Sciences